WeightWatchers to offer Novo Nordisk’s Wegovy pill after 2026 launch
Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg |…
An AI and ‘everything else’ market in play in the U.S.
Traders work on the floor of the New York Stock Exchange (NYSE) on Nov. 12, 2025 in New…
Trump deals with Lilly, Novo Nordisk could broaden obesity drug access
US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC…
Omada Health to start prescribing GLP-1s, other obesity medications
The Omada Health logo is displayed on a smartphone screen. Sopa Images | Lightrocket | Getty Images Virtual…
Trump strikes deal with Eli Lilly, Novo Nordisk
Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg |…
Metsera calls Novo Nordisk’s new bid superior to Pfizer offer
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
Pfizer files second lawsuit against Novo Nordisk, Metsera
A Pfizer logo is displayed at a research facility in the La Jolla neighborhood of San Diego, California,…
Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid
Thomas Fuller | SOPA Images | Lightrocket | Getty Images Pfizer said on Friday it had filed a lawsuit against Metsera and Novo…
Eli Lilly (LLY) earnings Q3 2025
David Ricks, chief executive officer of Eli Lilly & Co., during a news conference at Generation Park in…
Eli Lilly, Merck, Gilead and AbbVie earnings preview
The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in Singapore, on Thursday,…
A key step forward for Novo Nordisk’s GLP-1 pill
Novo Nordisk flags flutter outside their office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, July 14, 2025.…
Stock market today: Live updates
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., October…